Commercial and market access tools in this category use analytics and AI to understand patient, prescriber, and payer behaviour, inform pricing and access strategies, and optimise launch and in‑market performance across therapy areas. These AI solutions in healthcare are typically used in commercial, HEOR, and market access teams to support segmentation, forecasting, and evidence generation. Key evaluation angles include data quality and provenance, methodological robustness, handling of sensitive commercial and patient data, and alignment with regulatory and compliance expectations.
Browse the AI tools below to identify the Commercial & Market Access solutions that best match your data, workflow, and governance requirements.
This category page is for informational purposes only and does not constitute regulatory, clinical, or investment advice; organisations should conduct their own technical, legal, and governance due diligence before selecting any AI solutions in healthcare.
IQVIA Next Best Action is a strong choice for biotech commercial teams that need AI-driven recommendations embedded in omnichannel HCP engagement, sales, marketing, and commercial-operations workflows. Its recommendation engine uses rules- and machine-learning-based algorithms to prioritise customers, suggest the next action, channel, timing, and message, and connect those recommendations with CRM and commercial-execution systems. IQVIA states that the platform includes more than 200 extendable algorithms, pre-built data connectors, editable role-specific models, and integration with IQVIA OCE and other CRM environments.
Aktana is another leading option for biopharma teams that already have internal data-science models but need to operationalise them as contextual next-best actions across field, digital, and omnichannel engagement. In a vendor-published Top-10 biopharma case study, Aktana reports a 14% sales uplift among representatives who engaged more frequently with NBA recommendations; treat this as customer/vendor-reported rather than a guaranteed outcome.
For a biotech launch team, select an NBA engine that can ingest approved CRM, HCP/HCO, consent, interaction, content, and market-access data; explain why each recommendation was made; enforce promotional-review and channel-consent rules; and measure adoption, recommendation acceptance, engagement, and incremental lift.
